High value of combined serum c-reactive protein and bode score for mortality prediction in patients with stable COPD;Alto valor de la combinación de la concentración sérica de proteína C reactiva y la puntuación BODE para la predicción de la mortalidad en pacientes con EPOC estable

Archivos de Bronconeumologia

Volumn 47, Issue 9, 2011, Pages 427-432

  Liu, Shih Feng ^a,b   Wang, Chin Chou ^a   Chin, Chien Hung ^a   Chen, Yung Che ^a   Lin, Meng Chih ^a,b  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^b CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

Author keywords

BODE score; C reactive protein; Chronic obstructive pulmonary disease

Indexed keywords

C REACTIVE PROTEIN; FIBRINOGEN;

AIRWAY OBSTRUCTION; ARTICLE; BODE SCORE; BODY MASS; CHRONIC OBSTRUCTIVE LUNG DISEASE; COHORT ANALYSIS; DYSPNEA; EXERCISE; HUMAN; MAJOR CLINICAL STUDY; MORTALITY; PREDICTIVE VALUE; PROTEIN BLOOD LEVEL; RISK ASSESSMENT; SCORING SYSTEM; SURVIVAL RATE; AGE; AGED; CHINA; CONTROLLED STUDY; FEMALE; GENDER; MALE; MAXIMAL EXPIRATORY PRESSURE; MAXIMAL INSPIRATORY PRESSURE; MAXIMUM PLASMA CONCENTRATION; PROSPECTIVE STUDY; SMOKING; VERY ELDERLY;

EID: 85047696160     PISSN: 03002896     EISSN: 15792129     Source Type: Journal    
DOI: 10.1016/j.arbr.2011.04.010     Document Type: Article

References (26)

1. Pauwels R.A., Buist A.S., Calverley P.M., Jenkins C.R., Hurd S.S. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary. Am J Respir Crit Care Med 2001, 163:1256-1276. GOLD Scientific Committee.
2. Celli B.R., MacNee W. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J 2004, 23:932-946. ATS/ERS Task Force.
3. Pepys M.B., Hirschfield G.M. C-reactive protein: a critical update. J Clin Invest 2003, 111:1805-1812.
4. Gan W.Q., Man S.F.P., Senthilselvan A., Sin D.D. Association between chronic obstructive pulmonary disease and systemic inflammation: a systematic review and meta-analysis. Thorax 2004, 59:574-580.
5. Malo O., Sauleda J., Busquets X., Miralles C., Agusti A.G., Noguera A. Systemic inflammation during exacerbations of chronic obstructive pulmonary disease. Arch Bronconeumol 2002, 38:172-176.
6. Cano N.J., Pichard C., Roth H., Court-Fortuné I., Cynober L., Gérard-Boncompain M., et al. C-reactive protein and body mass index predict outcome in end-stage respiratory failure. Chest 2004, 126:540-546.
7. Sin D.D., Paul Man S.F. Why are patients with chronic obstructive pulmonary disease at increased risk of cardiovascular disease?. The potential role of systemic inflammation in chronic obstructive pulmonary disease. Circulation 2003, 107:1514-1519.
8. Man S.F., Connett J.E., Anthonisen N.R., Wise R.A., Tashkin D.P., Sin D.D. C-reactive protein and mortality in mild to moderate chronic obstructive pulmonary disease. Thorax 2006, 61:849-853.
9. Dahl M., Vestbo J., Lange P., Bojesen S.E., Tybjaerg-Hansen A., Nordestgaard B.G. C-reactive protein as a predictor of prognosis in COPD. Am J Respir Crit Care Med 2007, 175:250-255.
10. Celli B.R., Cote C.G., Marin J.M., Casanova C., Montes de Oca M., Mendez R.A., et al. The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med 2004, 350:1005-1012.
11. Ong K.C., Earnest A., Lu S.J. A multidimensional grading system (BODE index) as predictor of hospitalization for COPD. Chest 2005, 128:3810-3816.
12. Cote C.G., Celli B.R. Pulmonary rehabilitation and the BODE index in COPD. Eur Respir J 2005, 26:630-636.
13. de Oliveira H.G., Macedo-Neto A.V., John A.B., Jungblut S., Prolla J.C., Menna-Barreto S.S., et al. Transbronchoscopic pulmonary emphysema treatment: 1-month to 24-month endoscopic follow-up. Chest 2006, 130:190-199.
14. Imfeld S., Bloch K.E., Weder W., Russi E.W. The BODE index after lung volume reduction surgery correlates with survival. Chest 2006, 129:873-878.
15. Celli B.R. Change in the BODE index reflects disease modification in COPD: lessons from lung volume reduction surgery. Chest 2006, 129:835-836.
16. Quanjer P.H. Standardized lung function testing: report of the Working Party for the European Community for Steel and Coal. Bull Eur Physiopath Respir 1983, 19:22-27.
17. Myers G.L., Rifai N., Tracy R.P., Roberts W.L., Alexander R.W., Biasucci L.M., et al. CDC/AHA Workshop on Markers of Inflammation and Cardiovascular Disease. Circulation 2004, 110:545-549.
18. Ridker P. Clinical application of C-reactive protein for cardiovascular disease detection and prevention. Circulation 2003, 107:363-369.
19. Lung function testing: selection of reference values and interpretative strategies. Am Rev Respir Dis 1991, 144:1202-1218. American Thoracic Society Statement.
20. Mahler D., Wells C. Evaluation of clinical methods for rating dyspnea. Chest 1988, 93:580-586.
21. ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med 2002, 166:111-117. ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories.
22. Pinto-Plata V.M., Müllerova H., Toso J.F., Feudjo-Tepie M., Soriano J.B., Vessey R.S., et al. C-reactive protein in patients with COPD, control smokers, and nonsmokers. Thorax 2006, 61:23-28.
23. de Torres J.P., Cordoba-Lanus E., López-Aguilar C., Muros de Fuentes M., Montejo de Garcini A., Aguirre-Jaime A., et al. C-reactive protein levels and clinically important predictive outcomes in stable COPD patients. Eur Respir J 2006, 27:902-907.
24. de Torres J.P., Pinto-Plata V., Casanova C., Mullerova H., Córdoba-Lanús E., Muros de Fuentes M., et al. C-reactive protein levels and survival in patients with moderate to very severe COPD. Chest 2008, 133:1336-1343.
25. Tuomisto K., Jousilahti P., Sundvall J., Pajunen P., Salomaa V. C-reactive protein, interleukin-6 and tumor necrosis factor alpha as predictors of incident coronary and cardiovascular events and total mortality. A population-based, prospective study. Thromb Haemost 2006, 95:511-518.
26. Tice J.A., Browner W., Tracy R.P., Cummings S.R. The relation of C-reactive protein levels to total and cardiovascular mortality in older U.S. women. Am J Med 2003, 114:199-205.